Cargando…
First Onset of IgA Vasculitis and Nephritis Following COVID-19 Vaccination
The article presents a case of a 32-year-old male who developed IgA vasculitis (IgAV) and IgA vasculitis nephritis (IgAVN) after receiving the second dose of the AstraZeneca COVID-19 vaccine. IgAVN can be a rare side effect of COVID-19 vaccines. Healthcare providers should be aware of this potential...
Autores principales: | Martínez-Ortega, Jesús Iván, Perez-Hernandez, Felipe, Fernández-Reyna, Ilse, Eljure Lopez, Nixma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449366/ https://www.ncbi.nlm.nih.gov/pubmed/37637560 http://dx.doi.org/10.7759/cureus.42448 |
Ejemplares similares
-
Drug-Induced IgA Vasculitis in an Adult
por: Yousif, Miranda, et al.
Publicado: (2023) -
IgA Vasculitis Associated With COVID-19
por: Salem, Yousef, et al.
Publicado: (2023) -
IgA Vasculitis Followed by IgA Nephropathy Without an Identifiable Trigger: The Same Disease or a Spectrum of Related Conditions?
por: Lapides, Rebecca, et al.
Publicado: (2023) -
Adult Onset Immunoglobulin A (IgA) Vasculitis Secondary to Group A Streptococcus Infection
por: Wallace, Carly E, et al.
Publicado: (2022) -
An Unusual Timing of Amoxicillin-Induced IgA Vasculitis in an Elderly Patient
por: Fohle, Emmanuel, et al.
Publicado: (2021)